Innovative Obesity Solution BFKW LLC has developed the revolutionary Full Sense™ Device, a minimally invasive implantable device that induces long-lasting satiety, positioning it as a potential replacement for traditional bariatric surgeries and appealing to healthcare providers seeking less invasive obesity treatments.

Strong Patent Portfolio The company holds extensive patent protections across key markets including the US, EU, Australia, China, and Russia, providing competitive barriers and opportunities for licensing or partnerships with medical device manufacturers and strategic investors.

Recent Funding Boost With a recent $2.1 million financing round aimed at expanding clinical trials, BFKW LLC is positioned for growth, making it attractive for stakeholders interested in early-stage medical device innovations and commercialization opportunities.

High Clinical Efficacy Successful preclinical evaluations and implantation in over 50 patients with no non-responders demonstrate strong clinical potential, making the device appealing for healthcare providers and clinics seeking effective obesity treatment options.

Growing Market Potential As a novel, less invasive alternative to traditional bariatric procedures, the Full Sense™ Device aligns with market trends toward minimally invasive procedures and patient-centered care, offering sales opportunities in hospitals, clinics, and health systems focused on obesity management.